Dergiler / İstanbul Kuzey Klinikleri / 2018 / Cilt: 5 - Sayı: 2

Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption

Sayfa
109–113
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, patients with cirrhosis andintensive alcohol consumption should be screened for hepatitis B and C.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: The objective of this study was to evaluate the serology of hepatitis A, B, and C in patients with cirrhosis andintensive alcohol consumption.METHODS: We retrospectively reviewed the viral serology results of 817 patients with cirrhosis and intensive alcohol consumptionwho presented to the Gastroenterology Clinic of Atatürk Training and Research Hospital of Izmir Katip Çelebi Universitybetween April 2008 and December 2017.
📊
Temel Bulgular & Veri:Patients consuming absolute alcohol 40 g/day for >10 years were included and those who quit drinking≥15 years ago were excluded.RESULTS: Of all the patients, 806 (98.7%) were positive for anti-HAV IgG, 159 (19.5%) for HBsAg, and 32 (3.9%) for anti-HCV.
💡
Sonuç & Katkı:Therefore, patients with cirrhosis andintensive alcohol consumption should be screened for hepatitis B and C.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2008 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: The objective of this study was to evaluate the serology of hepatitis A, B, and C in patients with cirrhosis andintensive alcohol consumption.METHODS: We retrospectively reviewed the viral serology results of 817 patients with cirrhosis and intensive alcohol consumptionwho presented to the Gastroenterology Clinic of Atatürk Training and Research Hospital of Izmir Katip Çelebi Universitybetween April 2008 and December 2017. The diagnosis of cirrhosis was based on clinical and biochemical evaluationsand imaging results. Patients consuming absolute alcohol 40 g/day for >10 years were included and those who quit drinking≥15 years ago were excluded.RESULTS: Of all the patients, 806 (98.7%) were positive for anti-HAV IgG, 159 (19.5%) for HBsAg, and 32 (3.9%) for anti-HCV. Genotyping was performed in 13 patients. Genotype 1 was detected in 10 patients (1a, one patient; 1b, nine patients)and genotype 3 in three patients. Of the patients with HBV, 10.0% had HBeAg and 7.6% had anti-delta. One-hundred andtwo (12.5%) patients had HCC, and of these, six (5.9%) were HCV-positive and 53 (52.0%) were HBsAg-positive.CONCLUSION: Patients with cirrhosis and intensive alcohol consumption have an increased hepatitis B and C prevalence.Patients with chronic viral hepatitis with alcohol habit are at a higher risk for HCC. Therefore, patients with cirrhosis andintensive alcohol consumption should be screened for hepatitis B and C.

🔖

Bu Makaleye Atıf Yap

VATANSEVER, S., ÜNSAL, B., PAKÖZ, Z. B. (2022). Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption. İstanbul Kuzey Klinikleri, Cilt: 5 - Sayı: 2, 109–113. https://ajindex.com/articles/551520

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Maher JJ. Alcoholic liver disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Gastrointestinal and Liver Disease Vol II. Philadelphia: Saunders; 2002. p. 1375–91. European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012;57:399–420.
  2. Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 2009;15:3462–71. World Health Organization. Global status report on alcohol and health. Available at: http://www.who.int/substance_abuse/publications/ global_alcohol_report/en/. Accessed Apr 26, 2018.
  3. Anand BS, Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, et al; VAHCV- 001 Study Group. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology 2006;130:1607– 16. Bhattacharya R, Shuhart MC. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 2003;36:242–52.
  4. Costentin CE, Trabut JB, Mallet V, Darbeda S, Thépot V, Nalpas B, et al. Management of hepatitis C virus infection in heavy drinkers. Alcohol Alcohol 2013;48:337–42. de Oliveira LC, Buso AG, de Oliveira AT, Arantes CA, Borges LV, Valente SR. Prevalence of hepatitis B and hepatitis C markers in alcoholics with and without clinically evident hepatic cirrhosis. Rev Inst Med Trop Sao Paulo 1999;41:69–73.
  5. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206–13.
  6. Stroffolini T, Cotticelli G, Medda E, Niosi M, Del Vecchio-Blanco C, Addolorato G, et al. Interaction of alcohol intake and cofactors on the risk of cirrhosis. Liver Int 2010;30:867–70.
  7. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 1997;26:579–84.
  8. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca US, et al. A nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Hepatology 2010;52 Supp1:697. Novo-Veleiro I, Calle Cde L, Domínguez-Quibén S, Pastor I, Marcos M, Laso FJ. Prevalence of hepatitis C virus infection in alcoholic patients: cohort study and systematic review. Alcohol Alcohol 2013;48:564–9.
  9. Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, Ikuta N. P